PMC:7268883 / 7716-9127 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"131","span":{"begin":246,"end":254},"obj":"Species"},{"id":"140","span":{"begin":1329,"end":1332},"obj":"Gene"},{"id":"141","span":{"begin":1298,"end":1301},"obj":"Gene"},{"id":"142","span":{"begin":1267,"end":1270},"obj":"Gene"},{"id":"143","span":{"begin":679,"end":687},"obj":"Species"},{"id":"144","span":{"begin":856,"end":863},"obj":"Species"},{"id":"145","span":{"begin":1001,"end":1009},"obj":"Species"},{"id":"146","span":{"begin":1021,"end":1029},"obj":"Disease"},{"id":"147","span":{"begin":1211,"end":1219},"obj":"Disease"}],"attributes":[{"id":"A131","pred":"tao:has_database_id","subj":"131","obj":"Tax:9606"},{"id":"A140","pred":"tao:has_database_id","subj":"140","obj":"Gene:6503"},{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"Gene:6503"},{"id":"A142","pred":"tao:has_database_id","subj":"142","obj":"Gene:6503"},{"id":"A143","pred":"tao:has_database_id","subj":"143","obj":"Tax:9606"},{"id":"A144","pred":"tao:has_database_id","subj":"144","obj":"Tax:9606"},{"id":"A145","pred":"tao:has_database_id","subj":"145","obj":"Tax:9606"},{"id":"A146","pred":"tao:has_database_id","subj":"146","obj":"MESH:C000657245"},{"id":"A147","pred":"tao:has_database_id","subj":"147","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Sensitivity Analyses\nThe statement outcomes barely changed after excluding the nonacademic centers, without any shifts in the 3 categories of agreement. Exclusion of nonsurgeons lead to the movement of statement 5—regarding the prioritization of patients with limited/without comorbidity for surgery to increase the ICU capacity—to the lowest group of agreement (61.1%–59.9%).\nAnalyzing the outcomes of Europe (n = 149, 44.2%), Asia (n = 115, 34.1%), and the Americas (ie, North and South America) (n = 71, 21.1%) separately demonstrated some changes in agreement. The European respondents did not reach consensus on statement 3 (76.5% agreement) regarding the prioritization of patients based on objective prognostic factors and comorbidity. In contrast to the overall outcomes, Asia achieved consensus on statement 4 (81.7% agreement) to prioritize each patient for pancreatic surgery, based on prognostic factors. Whereas Europe agreed on the importance of high-volume centers to operate high-risk patients during the COVID-19 pandemic (87.9% agreement), both Asia (75.7% agreement) and the Americas (76.1% agreement) did not reach consensus on statement 16. The recommendation for preoperative screening on COVID-19 (statement 19) reached solely consensus (84.5% agreement) in the Americas. See Table—Supplemental Digital Content 2–4, for the statement outcomes of Europe, Asia, and the Americas separately."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T65","span":{"begin":1021,"end":1029},"obj":"Disease"},{"id":"T66","span":{"begin":1211,"end":1219},"obj":"Disease"}],"attributes":[{"id":"A65","pred":"mondo_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A66","pred":"mondo_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Sensitivity Analyses\nThe statement outcomes barely changed after excluding the nonacademic centers, without any shifts in the 3 categories of agreement. Exclusion of nonsurgeons lead to the movement of statement 5—regarding the prioritization of patients with limited/without comorbidity for surgery to increase the ICU capacity—to the lowest group of agreement (61.1%–59.9%).\nAnalyzing the outcomes of Europe (n = 149, 44.2%), Asia (n = 115, 34.1%), and the Americas (ie, North and South America) (n = 71, 21.1%) separately demonstrated some changes in agreement. The European respondents did not reach consensus on statement 3 (76.5% agreement) regarding the prioritization of patients based on objective prognostic factors and comorbidity. In contrast to the overall outcomes, Asia achieved consensus on statement 4 (81.7% agreement) to prioritize each patient for pancreatic surgery, based on prognostic factors. Whereas Europe agreed on the importance of high-volume centers to operate high-risk patients during the COVID-19 pandemic (87.9% agreement), both Asia (75.7% agreement) and the Americas (76.1% agreement) did not reach consensus on statement 16. The recommendation for preoperative screening on COVID-19 (statement 19) reached solely consensus (84.5% agreement) in the Americas. See Table—Supplemental Digital Content 2–4, for the statement outcomes of Europe, Asia, and the Americas separately."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T24","span":{"begin":503,"end":505},"obj":"http://purl.obolibrary.org/obo/CLO_0054055"},{"id":"T25","span":{"begin":697,"end":706},"obj":"http://purl.obolibrary.org/obo/BFO_0000030"},{"id":"T26","span":{"begin":1318,"end":1325},"obj":"http://www.ebi.ac.uk/efo/EFO_0000881"}],"text":"Sensitivity Analyses\nThe statement outcomes barely changed after excluding the nonacademic centers, without any shifts in the 3 categories of agreement. Exclusion of nonsurgeons lead to the movement of statement 5—regarding the prioritization of patients with limited/without comorbidity for surgery to increase the ICU capacity—to the lowest group of agreement (61.1%–59.9%).\nAnalyzing the outcomes of Europe (n = 149, 44.2%), Asia (n = 115, 34.1%), and the Americas (ie, North and South America) (n = 71, 21.1%) separately demonstrated some changes in agreement. The European respondents did not reach consensus on statement 3 (76.5% agreement) regarding the prioritization of patients based on objective prognostic factors and comorbidity. In contrast to the overall outcomes, Asia achieved consensus on statement 4 (81.7% agreement) to prioritize each patient for pancreatic surgery, based on prognostic factors. Whereas Europe agreed on the importance of high-volume centers to operate high-risk patients during the COVID-19 pandemic (87.9% agreement), both Asia (75.7% agreement) and the Americas (76.1% agreement) did not reach consensus on statement 16. The recommendation for preoperative screening on COVID-19 (statement 19) reached solely consensus (84.5% agreement) in the Americas. See Table—Supplemental Digital Content 2–4, for the statement outcomes of Europe, Asia, and the Americas separately."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":343,"end":348},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Sensitivity Analyses\nThe statement outcomes barely changed after excluding the nonacademic centers, without any shifts in the 3 categories of agreement. Exclusion of nonsurgeons lead to the movement of statement 5—regarding the prioritization of patients with limited/without comorbidity for surgery to increase the ICU capacity—to the lowest group of agreement (61.1%–59.9%).\nAnalyzing the outcomes of Europe (n = 149, 44.2%), Asia (n = 115, 34.1%), and the Americas (ie, North and South America) (n = 71, 21.1%) separately demonstrated some changes in agreement. The European respondents did not reach consensus on statement 3 (76.5% agreement) regarding the prioritization of patients based on objective prognostic factors and comorbidity. In contrast to the overall outcomes, Asia achieved consensus on statement 4 (81.7% agreement) to prioritize each patient for pancreatic surgery, based on prognostic factors. Whereas Europe agreed on the importance of high-volume centers to operate high-risk patients during the COVID-19 pandemic (87.9% agreement), both Asia (75.7% agreement) and the Americas (76.1% agreement) did not reach consensus on statement 16. The recommendation for preoperative screening on COVID-19 (statement 19) reached solely consensus (84.5% agreement) in the Americas. See Table—Supplemental Digital Content 2–4, for the statement outcomes of Europe, Asia, and the Americas separately."}

{"project":"LitCovid-sentences","denotations":[{"id":"T67","span":{"begin":0,"end":20},"obj":"Sentence"},{"id":"T68","span":{"begin":21,"end":152},"obj":"Sentence"},{"id":"T69","span":{"begin":153,"end":376},"obj":"Sentence"},{"id":"T70","span":{"begin":377,"end":564},"obj":"Sentence"},{"id":"T71","span":{"begin":565,"end":742},"obj":"Sentence"},{"id":"T72","span":{"begin":743,"end":916},"obj":"Sentence"},{"id":"T73","span":{"begin":917,"end":1161},"obj":"Sentence"},{"id":"T74","span":{"begin":1162,"end":1294},"obj":"Sentence"},{"id":"T75","span":{"begin":1295,"end":1411},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Sensitivity Analyses\nThe statement outcomes barely changed after excluding the nonacademic centers, without any shifts in the 3 categories of agreement. Exclusion of nonsurgeons lead to the movement of statement 5—regarding the prioritization of patients with limited/without comorbidity for surgery to increase the ICU capacity—to the lowest group of agreement (61.1%–59.9%).\nAnalyzing the outcomes of Europe (n = 149, 44.2%), Asia (n = 115, 34.1%), and the Americas (ie, North and South America) (n = 71, 21.1%) separately demonstrated some changes in agreement. The European respondents did not reach consensus on statement 3 (76.5% agreement) regarding the prioritization of patients based on objective prognostic factors and comorbidity. In contrast to the overall outcomes, Asia achieved consensus on statement 4 (81.7% agreement) to prioritize each patient for pancreatic surgery, based on prognostic factors. Whereas Europe agreed on the importance of high-volume centers to operate high-risk patients during the COVID-19 pandemic (87.9% agreement), both Asia (75.7% agreement) and the Americas (76.1% agreement) did not reach consensus on statement 16. The recommendation for preoperative screening on COVID-19 (statement 19) reached solely consensus (84.5% agreement) in the Americas. See Table—Supplemental Digital Content 2–4, for the statement outcomes of Europe, Asia, and the Americas separately."}